Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1978-2-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0078-5334
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
97
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
196-201
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:339413-Clinical Trials as Topic,
pubmed-meshheading:339413-Depression, Chemical,
pubmed-meshheading:339413-Drug Therapy, Combination,
pubmed-meshheading:339413-Epinephrine,
pubmed-meshheading:339413-Glaucoma,
pubmed-meshheading:339413-Guanethidine,
pubmed-meshheading:339413-Humans,
pubmed-meshheading:339413-Intraocular Pressure
|
pubmed:year |
1977
|
pubmed:articleTitle |
Use of guanethidine 5% and adrenaline 1% in the treatment of severe open angle glaucoma.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|